Publisher
Springer Berlin Heidelberg
Reference58 articles.
1. Aberg Wisted A (1989) The antidepressant effects of 5 HT uptake inhibitors. [Symposium of the XVIth Collegium Internationale Neuropsychopharmacologicum: Serotonin in behavioral disorders. 1988, München]. Br J Psychiatry 155 [Suppl 8]:32–40
2. Berger M, Emrich HM, Lund R, Riemann D, Lauer C, von Zerssen D (1985) Schlaf-EEG-Variablen als Verlaufskriterien und Prädiktoren einer Antidepressivatherapie mit Fluvoxamin/Oxaprotilin. In: Hippius H, Matussek N (eds) Differential therapy of depression: possibilities and limitations (Advances in Pharmacotherapy, vol 2). Karger, Basel, pp 120–131
3. Binnie GA (1983) Psychotropic drugs and accidents in a general practice. Br Med J 287:1349–1350
4. Blanchard JC, Zundel JL, Julou L (1983) Differences between Cyclopyrrolones (suricone and zopiclone) and benzodiazepines binding to rat hippocampus photolabelled membranes. Biochem Pharmacol 32:3651–3653
5. Boman B (1988) L-tryptophan: a rational antidepressant and natural hypnotic? Aust NZ Psychiatry 22:83–97